ALB was smacked ~9% overnight, the drop was primarily due to the company’s announcement that it would sell a controlling stake in its Ketjen refining catalyst solutions business to KPS Capital Partners for $US660mn. Albemarle will retain a 49% stake in Ketjen, which provides products to the petrochemical and specialty chemical industries. The market gave the sale a big thumbs down, raising concerns among investors about Albemarle’s strategic direction and potential impacts on its future earnings
- We like the risk/reward towards ALB into overnight weakness, but note it has failed to keep pace with local names in 2025.